Related references
Note: Only part of the references are listed.The Impact of 68Ga-DOTATATE PET/CT Imaging on Management of Patients with Neuroendocrine Tumors: Experience from a National Referral Center in the United Kingdom
Evangelia Skoura et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
The epidemiology of metastases in neuroendocrine tumors
Matias Riihimaeki et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Comparative Performance of 18F-FDG PET/MRI and 18F-FDG PET/CT in Detection and Characterization of Pulmonary Lesions in 121 Oncologic Patients
Lino M. Sawicki et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
18F-FDG PET/CT and PET/MRI Perform Equally Well in Cancer: Evidence from Studies on More Than 2,300 Patients
Claudio Spicks et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Diagnosing Lung Nodules on Oncologic MR/PET Imaging: Comparison of Fast T1-Weighted Sequences and Influence of Image Acquisition in Inspiration and Expiration Breath-Hold
Nina F. Schwenzer et al.
KOREAN JOURNAL OF RADIOLOGY (2016)
Simultaneous 68Ga-DOTA-TOC PET/MRI with gadoxetate disodium in patients with neuroendocrine tumor
Thomas A. Hope et al.
ABDOMINAL IMAGING (2015)
Implementation of FAST-PET/MRI for whole-body staging of female patients with recurrent pelvic malignancies: A comparison to PET/CT
Johannes Grueneisen et al.
EUROPEAN JOURNAL OF RADIOLOGY (2015)
Somatostatin Receptor Imaging with 68Ga DOTATATE PET/CT: Clinical Utility, Normal Patterns, Pearls, and Pitfalls in Interpretation
Michael S. Hofman et al.
RADIOGRAPHICS (2015)
[18F]FDG PET/MRI vs. PET/CT for whole-body staging in patients with recurrent malignancies of the female pelvis: initial results
Karsten Beiderwellen et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
Whole-body [18F]FDG PET/MRI vs. PET/CT in the assessment of bone lesions in oncological patients: initial results
Karsten Beiderwellen et al.
EUROPEAN RADIOLOGY (2014)
Integrated PET/MR
Harald H. Quick
JOURNAL OF MAGNETIC RESONANCE IMAGING (2014)
PET/MR Imaging in the Detection and Characterization of Pulmonary Lesions: Technical and Diagnostic Evaluation in Comparison to PET/CT
Isabel Rauscher et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Somatostatin receptor PET/CT in neuroendocrine tumours: update on systematic review and meta-analysis
Hakan Geijer et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
Simultaneous 68Ga-DOTATOC PET/MRI in Patients With Gastroenteropancreatic Neuroendocrine Tumors Initial Results
Karsten J. Beiderwellen et al.
INVESTIGATIVE RADIOLOGY (2013)
Evaluation of the potential of PET-MRI fusion for detection of liver metastases in patients with neuroendocrine tumours
Nils F. Schreiter et al.
EUROPEAN RADIOLOGY (2012)
Diagnostic performance of Gallium-68 somatostatin receptor PET and PET/CT in patients with thoracic and gastroenteropancreatic neuroendocrine tumours: a meta-analysis
Giorgio Treglia et al.
ENDOCRINE (2012)
Molecular imaging with 68Ga-SSTR PET/CT and correlation to immunohistochemistry of somatostatin receptors in neuroendocrine tumours
Daniel Kaemmerer et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2011)
Prognostic factors influencing survival from metastatic (stage IV) gastroenteropancreatic well-differentiated endocrine carcinoma
Cosimo Durante et al.
ENDOCRINE-RELATED CANCER (2009)
Thirteen-Month Registration of Patients with Gastroenteropancreatic Endocrine Tumours in France
C. Lombard-Bohas et al.
NEUROENDOCRINOLOGY (2009)
One hundred years after Carcinoid: Epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States
James C. Yao et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Screening for bone metastases: whole-body MRI using a 32-channel system versus dual-modality PET-CT
Gerwin P. Schmidt et al.
EUROPEAN RADIOLOGY (2007)
Endocrine tumours of the pancreas
K Öberg et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2005)
Identification of somatostatin receptor subtypes 1, 2A, 3, and 5 in neuroendocrine tumours with subtype specific antibodies
H Kulaksiz et al.
GUT (2002)
Share Paper
